News Daily News Race, Socioeconomic Status Gaps in Revascularization Rates Persist Among Women With ACS Yael L. Maxwell April 05, 2019
News Conference News ACC 2019 Time and Money: PCI Public Reporting Requirements Take Their Toll Michael O'Riordan March 26, 2019
News Conference News ACC 2019 REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events Yael L. Maxwell March 22, 2019
News Conference News ACC 2019 High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI Michael O'Riordan March 21, 2019
News Conference News ACC 2019 Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom Michael O'Riordan March 20, 2019
News Opinion Editor's Corner ACC 2019 Live From New Orleans: Days 2 and 3 at ACC 2019 Shelley Wood March 18, 2019
News Conference News Flu Vaccination Tied to Less MI in Hospitalized Patients Todd Neale March 13, 2019
News Conference News CRT 2019 Rivaroxaban in Addition to DAPT Lowers Death, MI, Stroke in ACS, Heart Failure Patients: Meta-analysis Yael L. Maxwell March 03, 2019
News Daily News ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD Michael O'Riordan March 01, 2019
News Daily News CT Angiography Bests Functional Testing in Diabetic Patients With Chest Pain: PROMISE Michael O'Riordan February 25, 2019
News Conference News ISC 2019 Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade Todd Neale February 11, 2019
News Daily News High-Sensitivity Troponin Test Predicts Poor Outcomes in Stable Patients With Chest Pain Todd Neale January 22, 2019
News Daily News Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD Michael O'Riordan January 03, 2019
News Daily News Many PCI Patients Treated in China Have No Angina Symptoms Caitlin E. Cox December 20, 2018
News Daily News CTA an Effective Gatekeeper in Invasive Angiography Candidates With Suspected CAD Caitlin E. Cox December 14, 2018
News Daily News Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy Caitlin E. Cox November 28, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Conference News AHA 2018 REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides Todd Neale November 10, 2018
News Daily News ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom Michael O'Riordan November 07, 2018